The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 41 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Psoriasis  [Clear All Filters]
2019
Apalla, Z., Lallas A., Markakis K., Delli F., & Ioannides D. (2019).  Psoriasis, arthritis, and pyoderma gangrenosum: an autoinflammatory syndrome or a coincidence?. Int J Dermatol. 58(12), e240-e241.
Tsentemeidou, A., Sotiriou E., Vakirlis E., Sideris N., Papadimitriou I., Lazaridou E., et al. (2019).  Real-life efficacy and safety of secukinumab: results from a tertiary hospital in Greece.. J Eur Acad Dermatol Venereol. 33(2), e50-e51.
2018
Sgouros, D., Apalla Z., Ioannides D., Katoulis A., Rigopoulos D., Sotiriou E., et al. (2018).  Dermoscopy of Common Inflammatory Disorders.. Dermatol Clin. 36(4), 359-368.
Kyriakou, A., Patsatsi A., Sotiriadis D., & Goulis D. G. (2018).  Effects of treatment for psoriasis on circulating levels of leptin, adiponectin and resistin: a systematic review and meta-analysis.. Br J Dermatol. 179(2), 273-281.
Papathemeli, D., Georgiou E., Koletsa T., Sotiriadis D., & Patsatsi A. (2018).  Mycosis fungoides in patients with psoriasis: an ongoing issue.. Eur J Dermatol. 28(2), 235-236.
2017
Mendrinou, E., Patsatsi A., Zafiriou E., Papadopoulou D., Aggelou L., Sarri C., et al. (2017).  FCGR3A-V158F polymorphism is a disease-specific pharmacogenetic marker for the treatment of psoriasis with Fc-containing TNFα inhibitors.. Pharmacogenomics J. 17(3), 237-241.
Tragiannidis, A., Kyriakidis I., Zündorf I., & Groll A. H. (2017).  Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitors.. Mycoses. 60(4), 222-229.
Tsentemeidou, A., Vyzantiadis T-A., Kyriakou A., Sotiriadis D., & Patsatsi A. (2017).  Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study.. Mycoses. 60(12), 830-835.
2016
Babino, G., Moscarella E., Longo C., Lallas A., Ferrara G., Cusano F., et al. (2016).  Follicular psoriasis: an under-recognized condition.. J Eur Acad Dermatol Venereol. 30(8), 1397-9.
Fotiadou, C., Lazaridou E., Sotiriou E., Kyrgidis A., Apalla Z., & Ioannides D. (2016).  Scalp psoriasis and biologic agents: a retrospective, comparative study from a tertiary psoriasis referral centre.. J Eur Acad Dermatol Venereol. 30(12), 2091-2096.
2015
Di Lernia, V., Ficarelli E., Lallas A., Possemato N., Chiarolanza I., & Salvarani C. (2015).  Frequency of monoclonal gammopathy in psoriatic patients receiving anti-TNF therapy compared with patients taking conventional drugs: a cross-sectional study.. J Eur Acad Dermatol Venereol. 29(11), 2262-3.
Fotiadou, C., Lazaridou E., Sotiriou E., Gerou S., Kyrgidis A., Vakirlis E., et al. (2015).  IL-17A, IL-22, and IL-23 as Markers of Psoriasis Activity: A Cross-sectional, Hospital-based Study.. J Cutan Med Surg. 19(6), 555-60.
Apalla, Z., Sotiriou E., Trigoni A., & Ioannides D. (2015).  Psoriatic cheilitis: a report of 2 cases treated successfully with topical tacrolimus and a review of the literature.. Actas Dermosifiliogr. 106(8), 687-9.
Ardigo, M., Agozzino M., Longo C., Lallas A., Di Lernia V., Fabiano A., et al. (2015).  Reflectance confocal microscopy for plaque psoriasis therapeutic follow-up during an anti-TNF-α monoclonal antibody: an observational multicenter study.. J Eur Acad Dermatol Venereol. 29(12), 2363-8.
2014
Kyriakou, A., Patsatsi A., & Sotiriadis D. (2014).  The agreement among the different ways of measuring NAPSI and their correlation with DLQI.. J Dtsch Dermatol Ges. 12(11), 1051-3.
Di Lernia, V., Ricci C., Lallas A., & Ficarelli E. (2014).  Clinical predictors of non-response to any tumor necrosis factor (TNF) blockers: a retrospective study.. J Dermatolog Treat. 25(1), 73-4.
Moscarella, E., Argenziano G., Lallas A., Pellacani G., & Longo C. (2014).  Confocal microscopy: a new era in understanding the pathophysiologic background of inflammatory skin diseases.. Exp Dermatol. 23(5), 320-1.
Lallas, A., Apalla Z., Argenziano G., Sotiriou E., Di Lernia V., Moscarella E., et al. (2014).  Dermoscopic pattern of psoriatic lesions on specific body sites.. Dermatology. 228(3), 250-4.
Di Lernia, V., Ficarelli E., Lallas A., & Ricci C. (2014).  Familial aggregation of moderate to severe plaque psoriasis.. Clin Exp Dermatol. 39(7), 801-5.
Vasilopoulos, Y., Sarri C., Zafiriou E., Patsatsi A., Stamatis C., Ntoumou E., et al. (2014).  A pharmacogenetic study of ABCB1 polymorphisms and cyclosporine treatment response in patients with psoriasis in the Greek population.. Pharmacogenomics J. 14(6), 523-5.
Kouris, A., Pistiki A., Katoulis A., Georgitsi M., Giatrakou S., Papadavid E., et al. (2014).  Proinflammatory cytokine responses in patients with psoriasis.. Eur Cytokine Netw. 25(4), 63-8.
Kyriakou, A., Patsatsi A., & Sotiriadis D. (2014).  Quality of life and severity of skin and nail involvement in patients with plaque psoriasis.. Eur J Dermatol. 24(5), 623-5.
Kyriakou, A., Patsatsi A., Vyzantiadis T-A., & Sotiriadis D. (2014).  Serum levels of TNF- α , IL-12/23 p40, and IL-17 in psoriatic patients with and without nail psoriasis: a cross-sectional study.. ScientificWorldJournal. 2014, 508178.
Kyriakou, A., Patsatsi A., Vyzantiadis T-A., & Sotiriadis D. (2014).  Serum levels of TNF-α, IL-12/23p40, and IL-17 in plaque psoriasis and their correlation with disease severity.. J Immunol Res. 2014, 467541.
Stefanello, B., Rezende P. Makino, Argenziano G., Piana S., Moscarella E., Longo C., et al. (2014).  Uncovering a hidden basal cell carcinoma.. J Am Acad Dermatol. 70(5), e99-101.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.